Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagen Bioinnovation is a Turkish biotechnology company specializing in the development and manufacture of molecular diagnostic systems and real-time PCR kits. Headquartered in the METU Technopolis, the company produces a comprehensive range of "Dia-Kit" products for the detection and quantification of infectious diseases, including HBV, HCV, HPV, and COVID-19. Beyond infectious diseases, Diagen offers specialized kits for genetic mutation analysis related to conditions such as Familial Mediterranean Fever and Thrombophilia. The company integrates high-level R&D with manufacturing to provide clinical laboratories and hospitals with sensitive, standardized diagnostic tools. Their operations encompass both the domestic Turkish market and international exports, contributing to the advancement of personalized medicine and molecular diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagen Bioinnovation.